160 related articles for article (PubMed ID: 12593536)
1. Distribution of allelic variants of functional C3435T polymorphism of drug transporter MDR1 gene in a sample of Polish population.
Jamroziak K; Balcerczak E; Młynarski W; Mirowski M; Robak T
Pol J Pharmacol; 2002; 54(5):495-500. PubMed ID: 12593536
[TBL] [Abstract][Full Text] [Related]
2. MDR1 C3435T polymorphism in patients with breast cancer.
Turgut S; Yaren A; Kursunluoglu R; Turgut G
Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
[TBL] [Abstract][Full Text] [Related]
3. Genotype and allele frequencies of MDR1 gene C1236T polymorphism in a Turkish population.
Gümüş-Akay G; Rüstemoğlu A; Karadağ A; Sunguroğlu A
Genet Mol Res; 2008 Oct; 7(4):1193-9. PubMed ID: 19048498
[TBL] [Abstract][Full Text] [Related]
4. A variant 2677A allele of the MDR1 gene affects fexofenadine disposition.
Yi SY; Hong KS; Lim HS; Chung JY; Oh DS; Kim JR; Jung HR; Cho JY; Yu KS; Jang IJ; Shin SG
Clin Pharmacol Ther; 2004 Nov; 76(5):418-27. PubMed ID: 15536457
[TBL] [Abstract][Full Text] [Related]
5. Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment.
Sills GJ; Mohanraj R; Butler E; McCrindle S; Collier L; Wilson EA; Brodie MJ
Epilepsia; 2005 May; 46(5):643-7. PubMed ID: 15857428
[TBL] [Abstract][Full Text] [Related]
6. The genetic variability of MDR1 C3435T polymorphisms in four Southern Chinese populations.
Dong Q; Xu B; Tan Y; Liu Z; Tian L; Zhang B; Lin CK; Kung HF; Sung JJ; He ML
Biomed Pharmacother; 2009 Nov; 63(9):658-62. PubMed ID: 18926661
[TBL] [Abstract][Full Text] [Related]
7. P-glycoprotein drug transporter MDR1 gene polymorphism in renal transplant patients with and without gingival overgrowth.
Drozdzik M; Mysliwiec K; Lewinska-Chelstowska M; Banach J; Drozdzik A; Grabarek J
J Clin Periodontol; 2004 Sep; 31(9):758-63. PubMed ID: 15312098
[TBL] [Abstract][Full Text] [Related]
8. Effect of MDR1 polymorphism on multidrug resistance expression in breast cancer patients.
Taheri M; Mahjoubi F; Omranipour R
Genet Mol Res; 2010 Jan; 9(1):34-40. PubMed ID: 20082268
[TBL] [Abstract][Full Text] [Related]
9. Effect of MDR1 gene polymorphism on progression of end-stage renal disease.
Zhang WX; Chen B; Zhang W; Chen N; Yu ZC; Cai WM
Acta Pharmacol Sin; 2007 Apr; 28(4):579-83. PubMed ID: 17376299
[TBL] [Abstract][Full Text] [Related]
10. Relationship between the C3435T and G2677T(A) polymorphisms in the ABCB1 gene and P-glycoprotein expression in human liver.
Owen A; Goldring C; Morgan P; Chadwick D; Park BK; Pirmohamed M
Br J Clin Pharmacol; 2005 Mar; 59(3):365-70. PubMed ID: 15752383
[TBL] [Abstract][Full Text] [Related]
11. CYP3A5*3 and MDR-1 C3435T single nucleotide polymorphisms in six Chinese ethnic groups.
Lai Y; Zhang J; Wang YX; Wang XD; Li JL; Wang YH; Zeng YJ; Huang M
Pharmazie; 2011 Feb; 66(2):136-40. PubMed ID: 21434577
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease.
Droździk M; Białecka M; Myśliwiec K; Honczarenko K; Stankiewicz J; Sych Z
Pharmacogenetics; 2003 May; 13(5):259-63. PubMed ID: 12724617
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus dosing in Chinese renal transplant patients is related to MDR1 gene C3435T polymorphisms.
Li D; Gui R; Li J; Huang Z; Nie X
Transplant Proc; 2006 Nov; 38(9):2850-2. PubMed ID: 17112846
[TBL] [Abstract][Full Text] [Related]
14. No effect of MDR1 C3435T variant on loperamide disposition and central nervous system effects.
Pauli-Magnus C; Feiner J; Brett C; Lin E; Kroetz DL
Clin Pharmacol Ther; 2003 Nov; 74(5):487-98. PubMed ID: 14586389
[TBL] [Abstract][Full Text] [Related]
15. Determination of ABCB1 polymorphisms and haplotypes frequencies in a French population.
Jeannesson E; Albertini L; Siest G; Gomes AM; Ribeiro V; Aslanidis C; Schmitz G; Visvikis-Siest S
Fundam Clin Pharmacol; 2007 Aug; 21(4):411-8. PubMed ID: 17635180
[TBL] [Abstract][Full Text] [Related]
16. The effects of the human MDR1 genotype on the expression of duodenal P-glycoprotein and disposition of the probe drug talinolol.
Siegmund W; Ludwig K; Giessmann T; Dazert P; Schroeder E; Sperker B; Warzok R; Kroemer HK; Cascorbi I
Clin Pharmacol Ther; 2002 Nov; 72(5):572-83. PubMed ID: 12426521
[TBL] [Abstract][Full Text] [Related]
17. Multi-drug resistance 1 polymorphism is associated with reduced risk of gastric cancer in the Japanese population.
Tahara T; Arisawa T; Shibata T; Hirata I; Nakano H
J Gastroenterol Hepatol; 2007 Oct; 22(10):1678-82. PubMed ID: 17608636
[TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance in patients undergoing resective epilepsy surgery is not associated with C3435T polymorphism in the ABCB1 (MDR1) gene.
Dericioglu N; Babaoglu MO; Yasar U; Bal IB; Bozkurt A; Saygi S
Epilepsy Res; 2008 Jul; 80(1):42-6. PubMed ID: 18436433
[TBL] [Abstract][Full Text] [Related]
19. MDR1 gene polymorphisms and risk of gingival hyperplasia induced by calcium antagonists.
Meisel P; Giebel J; Kunert-Keil C; Dazert P; Kroemer HK; Kocher T
Clin Pharmacol Ther; 2006 Jan; 79(1):62-71. PubMed ID: 16413242
[TBL] [Abstract][Full Text] [Related]
20. [Effect of MDR1 polymorphic expression on oral disposition of cyclosporine A].
Jiao Z; Liang HQ; Ding JJ; Li ZD; Shi XJ; Zhong MK
Yao Xue Xue Bao; 2004 Dec; 39(12):971-4. PubMed ID: 15813023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]